Results 281 to 290 of about 179,002 (365)
Oral squamous cell carcinoma in a patient affected by chronic graft versus host disease. [PDF]
Decani S+4 more
europepmc +1 more source
Our study provides a comprehensive multi‐omics profile of aging, integrating proteomic, metabolomic, and metagenomic analyses across diverse tissues and plasma. We identified the synergistic amplification of the circulating complement system and tissue‐wide immunoglobulin accumulation as key molecular drivers of inflammaging.
Feng Zhang+17 more
wiley +1 more source
Extracellular vesicles: a new frontier in diagnosing and treating graft-versus-host disease after allogeneic hematopoietic cell transplantation. [PDF]
Wu P+5 more
europepmc +1 more source
This study explored the effect of plant‐derived indigo supplementation on intestinal inflammation using in vivo, in vitro, and clinical sample analyses. Our results showed that indigo decreased mucosal inflammation by regulating CD4+ T cell differentiation in a gut microbiota‐dependent manner.
Yunqi Xing+9 more
wiley +1 more source
Comparison of oral chronic graft-versus-host disease characteristics between patients with malignant and non-malignant hematopoietic disorders. [PDF]
Jiang Q+10 more
europepmc +1 more source
Reduction of graft-versus-host disease in neonatal Fl hybrid mice
Luisa DeGiorgi+3 more
openalex +2 more sources
Multi‐omics sequencing and correlation analysis identified the beneficial role of Faecalibacterium prausnitzii (F. prausnitzii)‐derived butyric acid (BA) as a key metabolite in the restoration of valve function in calcific aortic valve disease (CAVD). The therapeutic efficacy of BA in attenuating CAVD progression was confirmed in vitro, ex vivo, and in
Chunli Wang+18 more
wiley +1 more source
Uncommon finding in a pulmonary graft versus host disease: A first report of Tsukamurella pneumonia in a pulmonary graft-versus-host disease. [PDF]
Bertuccio FR+13 more
europepmc +1 more source
Research progress of antibody coupling technique in targeted drug delivery
Abstract Antibody‐drug conjugates are a cutting‐edge biotechnology recently attracting wide attention in the medical field. Binding antibodies to drug molecules could deliver drugs precisely to the site of the lesion, which shows great potential in the treatment of tumors and immune diseases.
Meng Li+6 more
wiley +1 more source